IMAPAC is the one-stop shop of market intelligence and business connections for the global biopharmaceutical industry. We help companies expand their influence, make data driven decisions through our industry intelligence, and link up with other biopharmaceutical professionals to exchange knowledge and engage in quality networking. At the core of IMAPAC is our mission to help biopharmaceutical businesses globally generate tangible growth. At the same time, our heart lies in giving back to society. We empower the next generation by equipping underprivileged children with an education. For every speaker and delegate participating in our events, a child from a developing country gets to go to school for an entire year.
Overview
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 11, 2025 | Amaran Biotech Wins Asia-Pacific Biologics CDMO Excellence Award for "Best Fill-Finish" | 50-Person Team Demonstrates Taiwan's Biotech Strength HSINCHU, Sept. 11, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was awarded the "Best Fill-Finish" at the ... |
| Mar 5, 2025 | Circio presents results that further validate the circVec circular RNA platform at two international industry conferences | Circio presents results that further validate the circVec circular RNA platform at two international industry conferences Wed, Mar 05, 2025 11:00 CET Report this content Oslo, Norway 5 March 2025 – Circio Holding ASA (OSE: CRNA), a biotechn... |
| Mar 1, 2025 | Circio and Moldova: Two Innovators Shaping the Future of Biotechnology and Digital Transformation | In the rapidly evolving landscape of biotechnology and digital innovation, two distinct narratives emerge from Europe: Circio Holding ASA in Norway and the Moldova Digital Summit. Both represent the pulse of progress, each in their own doma... |
| Mar 1, 2025 | The Future of RNA: Circio's Circular Revolution in Biotechnology | In the world of biotechnology, innovation is the lifeblood. Circio Holding ASA is at the forefront of this revolution. The company is pioneering circular RNA technology, a game-changer in the realm of nucleic acid medicine. This technology ... |
| Feb 26, 2025 | Circio invited to present advantages of circVec circular RNA technology at international industry conferences | Circio invited to present advantages of circVec circular RNA technology at international industry conferences Wed, Feb 26, 2025 07:00 CET Report this content Oslo, Norway 26 February 2025 – Circio Holding ASA (OSE: CRNA), a biotechnology co... |
| Mar 4, 2024 | Aptahem’s CSO to present at Biologics World Nordics Conference | Aptahem’s CSO to present at Biologics World Nordics Conference Mon, Mar 04, 2024 16:40 CET Report this content Aptahem’s CSO Dr Luiza Jedlina has been invited to speak at the Biologics World Nordics conference in Copenhagen on 7 March 2024.... |
| Mar 31, 2022 | Singapore’s Leading BioPharma Companies to Discuss Vaccines and Their Future at a Series of Hybrid IMAPAC Conferences, through Event Platform vFairs | SINGAPORE (PRWEB) March 31, 2022 IMAPAC is hosting three conferences from the 29th to the 31st of March, 2022, for leading biopharma companies to discuss the future of vaccines. These are the 9th Annual Biologics Manufacturing Asia 2022 Con... |
Reviews 0
FAQ about IMAPAC
When was IMAPAC founded?
IMAPAC was founded in 2010.
What has the press written about IMAPAC?
Parsers VC has collected 8 articles mentioning IMAPAC, among them “Amaran Biotech Wins Asia-Pacific Biologics CDMO Excellence Award for "Best Fill-Finish"” (Sep 11, 2025) and “Circio presents results that further validate the circVec circular RNA platform at two international industry conferences” (Mar 5, 2025).
Is IMAPAC still active?
Yes, IMAPAC is active; its latest activity on Parsers VC dates from Jul 1, 2026.